AGILENT

Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent focuses its products and solutions on six key markets: Food, Environmental and Forensics, Pharmaceutical, Diagnostics, Chemical and Energy, and Researc ...

Miembro Oro

Productos Covid-19

Covid-19 AGILENT

Laboratorio clínico

SARS-CoV-2 qRT-PCR IVD Test
SARS-CoV-2 qRT-PCR Dx Kit

The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. RNA is isolated and purified from nasopharyngeal, nasal, and oropharyngeal swab specimens obtained from individuals suspected of having COVID-19 by their healthcare provider. Clinical laboratories can easily generate diagnostic results from this single-tube assay.

Mas detalles

SARS-CoV-2 IgG ELISA Test
SARS-CoV-2 IgG ELISA Kit

The SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The qualitative two-step indirect ELISA for the detection of human IgG antibodies to the SARS-CoV-2 S1 RBD protein is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Mas detalles

SARS-CoV-2 qRT-PCR IVD Reagent Kit
SARS-CoV-2 qRT-PCR Dx Kit (CE-IVD)

The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. The CE-IVD marked kit contains a primer and probe mix that targets the N1 and N2 regions of the SARS-CoV-2 nucleocapsid gene and human RNase P, and includes a synthetic SARS-CoV-2 RNA positive control. RNA is isolated and purified from nasopharyngeal, nasal, and oropharyngeal swab specimens obtained from individuals suspected of having COVID-19 by their healthcare provider. The kit is validated for use with multiple automated RNA extraction systems and real-time PCR instruments and allows clinical laboratories to easily generate diagnostic results from this single-tube assay. • The Agilent SARS-CoV-2 qRT-PCR Dx kit is CE-IVD marked in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC. • For In Vitro Diagnostic Use

Mas detalles

SISTEMA DE PCR EN TIEMPO REAL
AriaMx Real-time PCR System

El sistema de PCR en tiempo real AriaMx es una solución qPCR totalmente integrada para amplificación, detección y análisis de datos, que combina un nuevo termociclador, un sistema óptico avanzado y un software de análisis de datos.

Mas detalles

SARS-CoV-2 qRT-PCR IVD Reagent Kit

Modelo:

SARS-CoV-2 qRT-PCR Dx Kit (CE-IVD)

Descripción:

Más info

Etiquetas: [Laboratorio clínico], [Pruebas Rápidas]

Descripción completa Características: Especificaciones:

Descripción

The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. The CE-IVD marked kit contains a primer and probe mix that targets the N1 and N2 regions of the SARS-CoV-2 nucleocapsid gene and human RNase P, and includes a synthetic SARS-CoV-2 RNA positive control. RNA is isolated and purified from nasopharyngeal, nasal, and oropharyngeal swab specimens obtained from individuals suspected of having COVID-19 by their healthcare provider. The kit is validated for use with multiple automated RNA extraction systems and real-time PCR instruments and allows clinical laboratories to easily generate diagnostic results from this single-tube assay.

• The Agilent SARS-CoV-2 qRT-PCR Dx kit is CE-IVD marked in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC.

• For In Vitro Diagnostic Use

Características:

• Single-tube qRT-PCR assay includes 3 targets: N1 and N23 viral targets and human RNase P
• Single tube assay minimizes use of consumables and maximizes sample throughput per instrument run
• Available as an optional stand-alone positive control
• Developed using primer and probe sequences published by the U.S. Centers for Disease Control (CDC)2
• Clinically validated and demonstrated with a limit of detection as low as 1.5 copies per µL
• Choose from two automated RNA extraction platforms
• Protocols for established 96-well real-time PCR systems for easy assay adoption on existing instruments

Especificaciones:

• Kit throughout: Validated protocols for 96 well plate formats
• Platform: CFX96 Touch Real-Time PCR Detection System (Bio-Rad)/Applied Biosystems 7500 Fast Real-Time PCR Instrument (Thermo Fisher Scientific)/AriaDx Real-Time PCR Instrument
• Primary Sample Type: Nasopharyngeal swab specimen/Nasal swab specimen/Oropharyngeal swab specimen
• Primer/Probe Sequences: Published by the U.S. Centers for Disease Control (CDC)
• Qualitative Reaction Speed: Fast Cycling
• Reaction Format: Single tube
• SARS-CoV-2 Viral RNA Controls: In-vitro transcribed N1 RNA/In-vitro transcribed N2 RNA
• SARS-CoV-2 Viral RNA Primer/Probes: N1/N2
• Sample Reaction Internal Control Primer/probe: Human RNAse P
• Sensitivity: Limit of detection (LoD) as low as 1.5 copies per µL ng
• Target Specificity: No cross-reactivity with 20 human respiratory pathogens, based on target sequences
• Technique: qPCR
• Validated RNA Extraction Systems and Reagents: MagMAX Viral/Pathogen II (MVP II) Nucleic Acid Isolation Kit with Automated KingFisher Flex system (Thermo Fisher Scientific); QIASymphony DSP Virus/Pathogen Midi Kit with automated QiaSymphony SP (Qiagen). Solicite información

Enviar un mensaje al proveedor

	* Información requerida
	Ingrese como
* Email:	Ya registrado
Clave:	Contraseña incorrecta Si tienes olvidó su contraseña por favor Haga clic .
Para	AGILENT ()
* Mensaje